Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Mikart LLC, a comprehensive contract development and manufacturing organization, acquired a state-of-the-art Korsch XM12 to meet their Pharmaceutical client demands for complex formulation development and production of oral solid dose products.
read more
Following the choice to embrace solar power, construction to reinforce the roof at NewAge Industries’ headquarters began in the summer of 2010. It culminated on June 8, 2011, when a group of the plastic tubing manufacturer’s employees flipped a ...
read more
SGD Pharma’s 20ml EasyLyo molded glass Type I vials are now available Ready-to-Use (RTU) in SG EZ-fill® Nest & Tub – an industry-recognized state-of-the-art secondary packaging format. Increased demand for parenteral drugs generated by the Covid-19 ...
read more
Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced the appointment of Terry Pizzie as Chief Executive Officer (CEO) of operating company Astrea Bioseparations. Pizzie succeeds Dr. Steve Burton, who will ...
read more
Sygnature Discovery announced the set-up of a state-of-the-art Early Candidate Developability Screening Group. The new service line expands the company’s portfolio into formal preclinical drug development. A new world-class facility with ...
read more
KBI Biopharma Inc., a JSR Life Sciences company, and AM-Pharma, an emerging leader focused on the development of therapeutics that protect organ function in patients with severe medical conditions, have signed a commercial manufacturing agreement to ...
read more
Coriolis Pharma, a globally operating service provider in formulation research and development of biopharmaceutical drugs, announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2).
read more
Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or ...
read more
APC Ltd, an Irish pharmaceutical research and development company, is investing €25M and creating 120 jobs through the formation of a ‘Global Centre of Excellence for Vaccine and Advanced Therapeutic Research and Manufacturing’.
read more
ValenzaBio, a biopharmaceutical company developing monoclonal antibody therapeutics for autoimmune and inflammatory indications, and Lonza announced that the companies have a manufacturing agreement in place.
read more
Solvias, a large independent analytical testing, contract research, development and manufacturing company, announced that it has acquired Canton, Mass.-based Chemic Laboratories, Inc. (Chemic). With this acquisition, Solvias gains a strong foothold ...
read more
ViiV Healthcare and Halozyme Therapeutics, Inc. announced a global collaboration and license agreement that gives exclusive access to Halozyme’s ENHANZE® drug delivery technology, recombinant human hyaluronidase PH20 enzyme (rHuPH20), for specific ...
read more
CellPoint, a cell therapy company developing CAR-T therapeutics for use at the point-of-care, announces an agreement with Lonza's Personalized Medicine Business Unit to employ Lonza's Cocoon® Platform for clinical manufacturing of CellPoint's CAR-T ...
read more
Breckenridge Pharmaceutical, Inc. announced the signing of a multi-product agreement with Aggrega Pharma, LLC. under which Aggrega will develop, manufacture and supply pharmaceutical products for marketing, sale and distribution by Breckenridge.
read more
Chemomab Therapeutics,Ltd., a clinical-stage biotech company focused on the discovery and development of innovative therapeutics for fibrosis-related diseases with high unmet need, and AGC Biologics, a global Biopharmaceutical Contract Development ...
read more